EBS - Emergent BioSolutions Inc.
Emergent BioSolutions Inc. , a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care.
As of May 15, 2026: spot at $7.98, ATM IV 68.8%, max pain $10.00, net GEX -$198.9K.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Market Cap
- $429.8M
- Beta
- 2.33
- 52-Week Range
- 5.31-14.06
- CEO
- Joseph C. Papa Jr.
- Employees
- 900
- IPO Date
- Nov 15, 2006
- Exchange
- NYSE
What EBS Looks Like to Options Traders Today
IV rank of 4.9% is subdued relative to the 1-year history, conditions that typically favor premium-buying or long-volatility structures (debit spreads, calendar spreads, long straddles); negative net gamma exposure (-$198.9K) means dealers hedge with trend, amplifying realized volatility and accelerating directional moves; the 25-delta skew (-0.166) prices puts richer than calls, the typical equity downside-protection skew.
What This Page Covers
The EBS overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked EBS overview questions
- What is EBS?
- EBS is the ticker symbol for Emergent BioSolutions Inc., a listed security. Emergent BioSolutions Inc. , a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. Listed on NYSE. EBS is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What does the EBS options snapshot look like today?
- As of May 15, 2026, the EBS options snapshot shows spot at $7.98, ATM IV 68.8%, IV rank 4.9%, max pain $10.00, net GEX -$198.9K, expected move 19.72%. The full options chain, Greeks by strike and expiration, per-strike open-interest distribution, dealer gamma and delta exposure, and the volatility skew surface are linked from this overview page. Each per-metric route refreshes once per trading session and reflects the most recent close-of-business listed-options state.
- What are EBS's key statistics?
- Emergent BioSolutions Inc. (EBS) carries a market capitalization of $429.8M, beta of 2.33 relative to the broader market, 52-week range of 5.31-14.06. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does EBS belong to?
- Emergent BioSolutions Inc. operates in the Healthcare sector, in the Drug Manufacturers - Specialty & Generic industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare EBS's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the EBS data on this page?
- The options snapshot above is dated May 15, 2026 and refreshes once per session, with all per-strike Greeks and exposure aggregates recomputed at the daily close. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).